1. Home
  2. MCRB vs LIDR Comparison

MCRB vs LIDR Comparison

Compare MCRB & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$8.65

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.60

Market Cap

118.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCRB
LIDR
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
118.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
MCRB
LIDR
Price
$8.65
$1.60
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$14.33
$6.00
AVG Volume (30 Days)
93.5K
582.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
2.40
N/A
Revenue
$126,325,000.00
N/A
Revenue This Year
N/A
$9.07
Revenue Next Year
N/A
$2,660.98
P/E Ratio
$3.43
N/A
Revenue Growth
1672.24
N/A
52 Week Low
$0.36
$0.49
52 Week High
$29.98
$6.44

Technical Indicators

Market Signals
Indicator
MCRB
LIDR
Relative Strength Index (RSI) 26.09 40.06
Support Level $7.12 $1.37
Resistance Level $8.49 $2.81
Average True Range (ATR) 1.13 0.11
MACD -0.42 0.02
Stochastic Oscillator 5.42 45.35

Price Performance

Historical Comparison
MCRB
LIDR

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: